Modulation of excitability, membrane currents and survival of cardiac myocytes by N-acylethanolamines

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 9, 2012, Pages 1167-1176

  Voitychuk, Oleg I ^a,c   Asmolkova, Valentyna S ^b   Gula, Nadiya M ^b   Sotkis, Ganna V ^a,c   Galadari, Sehamuddin ^d   Howarth, Frank C ^d   Oz, Murat ^d   Shuba, Yaroslav M ^a,c  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^c State Key Laboratory of Molecular and Cellular Physiology   (Ukraine)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cardiac myocyte; Endocannabinoid; Excitability; Ion channel

Indexed keywords

AMINE; CALCIUM CHANNEL L TYPE; N OLEOYLETHANOLAMINE; N STEAROYLETHANOLAMINE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CHANNEL GATING; CONTROLLED STUDY; ENDOCARDIUM; EPICARDIUM; HEART ATRIUM; HEART EXCITATION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE CONDUCTANCE; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; ION TRANSPORT; MEMBRANE CURRENT; NEWBORN; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNELS, L-TYPE; CELL SURVIVAL; ENDOCANNABINOIDS; ETHANOLAMINES; HEART ATRIA; ION TRANSPORT; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; OLEIC ACIDS; PERICARDIUM; RATS; STEARIC ACIDS; VOLTAGE-GATED SODIUM CHANNELS;

RATTUS;

EID: 84862272361     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.05.003     Document Type: Article

References (43)

1. H.H. Schmid, P.C. Schmid, and V. Natarajan The N-acylation- phosphodiesterase pathway and cell signalling Chem. Phys. Lipids 80 1996 133 142
2. H.S. Hansen, B. Moesgaard, H.H. Hansen, and G. Petersen N-Acylethanolamines and precursor phospholipids - relation to cell injury Chem. Phys. Lipids 108 2000 135 150
3. N. Ueda, K. Tsuboi, and T. Uyama Enzymological studies on the biosynthesis of N-acylethanolamines Biochim. Biophys. Acta 1801 2010 1274 1285
4. M. Maccarrone, and A. Finazzi-Agrò Endocannabinoids and their actions Vitam. Horm. 65 2002 225 255
5. V. Di Marzo Endocannabinoids, synthesis and degradation Rev. Physiol. Biochem. Pharmacol. 160 2008 1 24
6. D.E. Epps, P.C. Schmid, V. Natarajan, and H.H. Schmid N-Acylethanolamine accumulation in infarcted myocardium Biochem. Biophys. Res. Commun. 90 1979 628 633
7. N.R. Bachur, K. Masek, K.L. Melmon, and S. Udenfriend Fatty acid amides of ethanolamine in mammalian tissues J. Biol. Chem. 240 1965 1019 1024
8. D.E. Epps, V. Natarajan, P.C. Schmid, and H.O. Schmid Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium Biochim. Biophys. Acta 618 1980 420 430
9. D. Marsh, and M.J. Swamy Derivatised lipids in membranes. Physico-chemical aspects of N-biotinyl phosphatidylethanolamines, N-acylphosphatidylethanolamines and N-acylethanolamines Chem. Phys. Lipids 105 2000 43 69
10. O.I. Voitychuk, V.S. Asmolkova, N.M. Hula, H.V. Sotkis, M. Oz, and Ia.M. Shuba Regulation of the excitability of neonatal cardiomyocytes by N-stearoyl- and N-oleoyl-ethanolamines Fiziol. Zh. 55 2009 55 66 (Ukrainian)
11. O.I. Voitychuk, V.S. Asmolkova, N.M. Hula, M. Oz, and Ia.M. Shuba Effects of N-stearoyl- and N-oleoylethanolamine on cardiac voltage-dependent sodium channels Fiziol. Zh. 56 2010 13 22 (Ukrainian)
12. T.B. Rogers, S.T. Gaa, and I.S. Allen Identification and characterization of functional angiotensin II receptors on cultured heart myocytes J. Pharmacol. Exp. Ther. 236 1986 438 444
13. + modulates the cAMP-dependent regulation of ion channels in the heart Proc. Natl. Acad. Sci. U. S. A. 88 1991 6946 6950
14. + Cell Calcium 49 2011 162 173
15. J. Tamargo, R. Caballero, R. Gómez, C. Valenzuela, and E. Delpón Pharmacology of cardiac potassium channels Cardiovasc. Res. 62 2004 9 33
16. D. Duan Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart J. Physiol. 587 2009 2163 2177
17. M. Oz, Y. Tchugunova, and M. Dinc Differential effects of endocannabinoids and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids Eur. J. Pharmacol. 502 2004 47 58
18. M. Oz, A. Alptekin, Y. Tchugunova, and M. Dinc Effects of saturated long-chain N-acylethanolamines on voltage-dependent calcium fluxes in rabbit T-tubule membranes Arch. Biochem. Biophys. 434 2005 344 351
19. J. Chemin, J. Nargeot, and P. Lory Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels J. Biol. Chem. 282 2007 2314 2323
20. N.M. Gulaya, A.A. Melnik, D.I. Balkov, G.L. Volkov, M.V. Vysotskiy, and V.E. Vaskovsky The effect of long-chain N-acylethanolamines on some membrane-associated functions of neuroblastoma C1300 N18 cells Biochim. Biophys. Acta 1152 1993 280 288
21. B.G. Kelley, and S.A. Thayer Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors Eur. J. Pharmacol. 496 2004 33 39
22. W.A. Catterall, E. Perez-Reyes, T.P. Snutch, and J. Striessnig International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels Pharmacol. Rev. 57 2005 411 425
23. A. Alptekin, S. Galadari, Y. Shuba, G. Petroianu, and M. Oz The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels Eur. J. Pharmacol. 634 2010 10 15
24. Y. Kubo, J.P. Adelman, D.E. Clapham, L.Y. Jan, A. Karschin, Y. Kurachi, M. Lazdunski, C.G. Nichols, S. Seino, and C.A. Vandenberg International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels Pharmacol. Rev. 57 2005 509 526
25. A. Gurney, and B. Manoury Two-pore potassium channels in the cardiovascular system Eur. Biophys. J. 38 2009 305 318
26. H.H. Schmid, and E.V. Berdyshev Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function Prostaglandins Leukot. Essent. Fatty Acids 66 2002 363 376
27. H.H. Schmid, P.C. Schmid, and E.V. Berdyshev Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges Chem. Phys. Lipids 121 2002 111 134
28. L. De Petrocellis, J.B. Davis, and V. Di Marzo Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors FEBS Lett. 506 2001 253 256
29. K.O. Jonsson, S. Vandevoorde, D.M. Lambert, G. Tiger, and C.J. Fowler Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide Br. J. Pharmacol. 133 2001 1263 1275
30. D. Smart, K.O. Jonsson, S. Vandevoorde, D.M. Lambert, and C.J. Fowler 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism Br. J. Pharmacol. 136 2001 452 458
31. G. Godlewski, L. Offertáler, J.A. Wagner, and G. Kunos Receptors for acylethanolamides - GPR55 and GPR119 Prostaglandins Other Lipid Mediat. 89 2009 105 111
32. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, M.R. Elphick, P.J. Greasley, H.S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, and R.A. Ross International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 Pharmacol. Rev. 62 2010 528 531
33. M. Oz Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids Pharmacol. Ther. 111 2006 114 144
34. P. Movahed, B.A. Jönsson, B. Birnir, J.A. Wingstrand, T.D. Jorgensen, A. Ermund, O. Sterner, P.M. Zygmunt, and E.D. Högestätt Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists J. Biol. Chem. 280 2005 38496 38504
35. V. Di Marzo, and L. De Petrocellis Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs Curr. Med. Chem. 17 2010 1430 1449
36. H.S. Hansen, and A. Artmann Endocannabinoids and nutrition J. Neuroendocrinol. 20 Suppl. 1 2008 94 99
37. A.A. Izzo, F. Piscitelli, R. Capasso, P. Marini, L. Cristino, S. Petrosino, and V. Di Marzo Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats Obesity 18 2010 55 62
38. A. Barana, I. Amorós, R. Caballero, R. Gómez, L. Osuna, M.P. Lillo, C. Blázquez, M. Guzmán, E. Delpón, and J. Tamargo Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner Cardiovasc. Res. 85 2010 56 67
39. J.A. Lundbaek, P. Birn, A.J. Hansen, R. Sogaard, C. Nielsen, J. Girshman, M.J. Bruno, S.E. Tape, J. Egebjerg, D.V. Greathouse, G.L. Mattice, R.E. Koeppe, and O.S. Andersen Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of Micelle-forming amphiphiles and cholesterol J. Gen. Physiol. 123 2004 599 621
40. C.E. Spivak, C.R. Lupica, and M. Oz The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors Mol. Pharmacol. 72 2007 1024 1032
41. 2+-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities Curr. Opin. Neurobiol. 17 2007 360 365
42. H.S. Hansen, B. Moesgaard, G. Petersen, and H.H. Hansen Putative neuroprotective actions of N-acyl-ethanolamines Pharmacol. Ther. 95 2002 119 126
43. C. Berger, P.C. Schmid, W.R. Schabitz, M. Wolf, S. Schwab, and H.H. Schmid Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J. Neurochem. 88 2004 1159 1167